Synonym
FK-664; FK 664; FK664;
IUPAC/Chemical Name
2(1H)-Pyrimidinone, 6-(3,4-dimethoxyphenyl)-1-ethyl-3,4-dihydro-3-methyl-4-((2,4,6-trimethylphenyl)imino)-
InChi Key
OYGHXRNCHYRYRR-YYDJUVGSSA-N
InChi Code
InChI=1S/C24H29N3O3/c1-8-27-19(18-9-10-20(29-6)21(13-18)30-7)14-22(26(5)24(27)28)25-23-16(3)11-15(2)12-17(23)4/h9-14H,8H2,1-7H3/b25-22+
SMILES Code
CCN1C(=O)N(C)\C(=N\c2c(C)cc(C)cc2C)\C=C1c3ccc(OC)c(OC)c3
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
407.51
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Kodama I, Anno T, Sudo Y, Satake N, Shibata S. Electrophysiological effects of FK664, a new cardiotonic agent, on preparations from guinea pig ventricle and from rabbit sino-atrial node. Cardiovasc Res. 1989 May;23(5):369-77. doi: 10.1093/cvr/23.5.369. PMID: 2558795.
2: Sudo Y, Takai M, Esumi K. Improved heart failure protection by FK664, a novel positive inotropic agent, in dog heart-lung preparations. Life Sci. 1992;51(6):PL41-6. doi: 10.1016/0024-3205(92)90417-n. PMID: 1386131.
3: Miyamae A, Kitamura S, Tada T, Koda S, Yasuda T. X-ray structural studies and physicochemical characterization of (E)-6-(3,4-dimethoxyphenyl)-1-ethyl-4-mesitylimino-3-methyl- 3,4-dihydro-2(1H)-pyrimidinone polymorphs. J Pharm Sci. 1991 Oct;80(10):995-1000. doi: 10.1002/jps.2600801018. PMID: 1784011.
4: Sudo Y, Esumi K. The effect of FK664, a new cardiovascular drug, on systemic capacitance vessels in anesthetized dogs. Life Sci. 1992;51(25):PL261-5. doi: 10.1016/0024-3205(92)90120-e. PMID: 1453874.